OGEA-103: TOGAF Enterprise Architecture Combined Part 1 and Part 2 Exam

By The Open Group · Question Mode

QuestionQ36

VerifiedIntroduction to Applying the ADM

You are working as an Enterprise Architect within the Enterprise Architecture (EA) team at a healthcare and life sciences company. The company has multiple divisions, and your team operates within the healthcare division.

The EA team is working on an architecture project to develop a secure system that will allow healthcare researchers to share information more easily about their clinical trials. It will make collaboration easier across the organization. This system will also enable secure collaboration with external partners.

The company has an established EA practice and has adopted the TOGAF standard for use in its architecture work. The EA practice is federated, which allows some interoperability and information sharing between divisions while still permitting partially independent activity. The Vice President of the healthcare division is the sponsor of the Enterprise Architecture activity.

The EA team uses the TOGAF Architecture Development Method with adaptations required to support healthcare production methods and laboratory procedures. Because of the highly sensitive nature of the information that is managed, special care has been taken to ensure that each architecture domain considers privacy and safety concerns.

The healthcare division is always creating new products and needs to show the effectiveness and safety of the product. This happens in a set of clinical trials that satisfy the legal requirements of the relevant health authorities. The clinical trials are conducted by the division's research laboratories at multiple facilities worldwide. At any time, there are many clinical trials in progress.

In addition to internal research and development activities, the healthcare division is also involved in publicly funded research projects with industrial and academic partners.

The EA team has been instructed to minimize disruptions to the trials and to gradually introduce the new system.

You have been assigned to plan the introduction of the new system. Specifically, how would you identify the work packages?

Based on the TOGAF standard, which option is the best answer?

Explanation

TOGAF implementation planning uses an Implementation Factor Catalog to capture actions and constraints, and a Consolidated Gaps, Solutions and Dependencies Matrix to associate gaps with proposed solution approaches. Related activities are grouped into work packages, their dependencies are identified, and the packages are reorganized into Capability Increments delivered through a series of Transition Architectures. Clinical-trial schedules are a constraint that must be factored into that dependency and transition planning.

Community Discussion

No comments yet. Be the first to start the discussion!